Depakene (Valproic Acid Capsules) and Incruse Ellipta
Determining the interaction of Depakene (Valproic Acid Capsules) and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Depakene
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Depakene (Valproic Acid Capsules)-Indacaterol
- Depakene (Valproic Acid Capsules)-Indacaterol and Glycopyrrolate
- Depakene (Valproic Acid Capsules)-Indacaterol and glycopyrrolate Inhalation
- Depakene (Valproic Acid Capsules)-Indacaterol inhalation
- Depakene (Valproic Acid Capsules)-Indacaterol Maleate
- Depakene (Valproic Acid Capsules)-Indapamide
- Incruse Ellipta-Depakene (Valproic Acid Liquid)
- Incruse Ellipta-Depakote
- Incruse Ellipta-Depakote (Divalproex Long-Acting Tablets)
- Incruse Ellipta-Depakote (Divalproex Sprinkle Capsules)
- Incruse Ellipta-Depakote Capsules
- Incruse Ellipta-Depakote DR